AACR Project GENIE: 100,000 cases and beyond TJ Pugh, JL Bell, JP Bruce, GJ Doherty, M Galvin, MF Green, ... Cancer Discovery 12 (9), 2044-2057, 2022 | 56 | 2022 |
MatchMiner: an open-source platform for cancer precision medicine H Klein, T Mazor, E Siegel, P Trukhanov, A Ovalle, CD Vecchio Fitz, ... npj Precision Oncology 6 (1), 69, 2022 | 18 | 2022 |
Programmatic precision oncology decision support for patients with gastrointestinal cancer RB Keller, T Mazor, L Sholl, AJ Aguirre, H Singh, N Sethi, A Bass, ... JCO Precision Oncology 7, e2200342, 2023 | 7 | 2023 |
MatchMiner: Computational matching of cancer patients to precision medicine clinical trials T Mazor, P Kumari, J Lindsay, A Ovalle, E Siegel, J Yu, M Hassett, ... European Journal of Cancer 138, S18, 2020 | 2 | 2020 |
MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials T Mazor, RB Keller, P Kumai, J Lindsay, E Marriott, A Ovalle, E Siegel, ... Cancer Research 80 (16_Supplement), 3382-3382, 2020 | 1 | 2020 |
Abstract A024: MatchMiner: an open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials T Mazor, RB Keller, P Kumari, J Lindsay, E Marriott, A Ovalle, E Siegel, ... Molecular Cancer Therapeutics 18 (12_Supplement), A024-A024, 2019 | 1 | 2019 |
Design and adoption of MatchMiner at Dana-Farber Cancer Institute H Klein, T Mazor, P Kumari, A Ovalle, P Trukhanov, J Hansel, J Yu, ... Cancer Research 82 (12_Supplement), 4091-4091, 2022 | | 2022 |
Abstract P160: MatchMiner: An open-source platform for cancer precision medicine H Klein, T Mazor, P Kumari, J Lindsay, A Ovalle, P Trukhanov, J Yu, ... Molecular Cancer Therapeutics 20 (12_Supplement), P160-P160, 2021 | | 2021 |
MatchMiner: An open-source computational platform that accelerates patient enrollment on to precision medicine trials H Klein, T Mazor, P Kumari, J Lindsay, A Ovalle, E Siegel, P Trukhanov, ... Cancer Research 81 (13_Supplement), 1198-1198, 2021 | | 2021 |